Chen Yanover - Publications, H-index & Citations

Chen Yanover

ki research institute

24H指数

84论文数

2.0K被引数

收录论文 23

发表时间

Addressing the challenge of post-approval regulation of pharmaceuticals: The case for independent third-party evaluations 应对药品上市后监管的挑战：独立第三方评估的案例

Health Policy

IF3.4

2026-02-17

PREAI

Itai Bavli; Yair Sadaka; Chen Yanover; Joel Lexchin

Mental health risks in children with food allergies: a population-based comparison of food allergies with other chronic conditions 儿童食物过敏者的心理健康风险：一项基于人群的食物过敏与其他慢性疾病的比较研究

European Journal of Pediatrics

IF2.6

2025-07-16

PREAI

Natalie Flaks-Manov; Inbal Goldshtein; Chen Yanover; Idit Lachover-Roth

SNOMED CT entity linking challenge SNOMED CT实体链接挑战

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

IF4.6

2025-07-01

OAAI

Davidson, Rory; Hardman, Will; Amit, Guy; Bilu, Yonatan; Della Mea, Vincenzo; Galaida, Aleksandr; Girshovitz, Irena; Kulyabin, Mikhail; Horia Popescu, Mihai; Roitero, Kevin; Sokolov, Gleb; Yanover, Chen

EVALUATING FRAILTY INDEX INTEGRITY: INSIGHTS FROM AN INTERNATIONAL NETWORK STUDY 评估衰弱指数完整性：一项国际网络研究的见解

INNOVATION IN AGING

IF4.3

2024-12-31

OAAI

Cavanaugh, Robert; Yanover, Chen; Wong, Chelsea; El-Hay, Tal; Orkaby, Ariela; Bivas-Benita, Maytal; Akiva, Pinchas; Olivieri-Mui, Brianne

Non-osteoporotic fractures are associated with increased risk of subsequent major osteoporotic fractures 非骨质疏松性骨折与随后发生严重骨质疏松性骨折的风险增加有关

OSTEOPOROSIS INTERNATIONAL

IF5.4

2024-07-13

OAAI

Schwarcz, Yonatan; Yanover, Chen; Rouach, Vanessa; Luria, Shai; Goldshtein, Inbal

ISPE-Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID-19: Opportunities and Trade-Offs

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2022-03-11

OAAI

Sarri, Grammati; Bennett, Dimitri; Debray, Thomas; Deruaz-Luyet, Anouk; Gabarro, Montse Soriano; Largent, Joan A.; Li, Xiaojuan; Liu, Wei; Lund, Jennifer L.; Moga, Daniela C.; Gokhale, Mugdha; Rentsch, Christopher T.; Wen, Xuerong; Yanover, Chen; Ye, Yizhou; Yun, Huifeng; Zullo, Andrew R.; Lin, Kueiyu Joshua

Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19

SCIENTIFIC REPORTS

IF3.9

2021-10-14

OAAI

Mizrahi, Barak; Bivas-Benita, Maytal; Kalkstein, Nir; Akiva, Pinchas; Yanover, Chen; Yehezkelli, Yoav; Kessler, Yoav; Alon, Sharon Hermoni; Rubin, Eitan; Chodick, Gabriel

What Factors Increase the Risk of Complications in SARS-CoV-2-Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization 哪些因素会增加SARS-CoV-2-Infected患者并发症的风险？以色列全国卫生组织的一项队列研究

JMIR PUBLIC HEALTH AND SURVEILLANCE

IF3.9

2020-08-25

OAAI

Yanover, Chen; Mizrahi, Barak; Kalkstein, Nir; Marcus, Karni; Akiva, Pinchas; Barer, Yael; Shalev, Varda; Chodick, Gabriel

Comment: Causal Inference Competitions: Where Should We Aim?

STATISTICAL SCIENCE

IF3.4

2019-02-01

OAAI

Karavani, Ehud; El-Hay, Tal; Shimoni, Yishai; Yanover, Chen

Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2017-11-30

OAAI

Gottlieb, Assaf; Yanover, Chen; Cahan, Amos; Goldschmidt, Yaara

Paradoxical Hypersusceptibility of Drug-resistant Mycobacterium tuberculosis to β-lactam Antibiotics

EBIOMEDICINE

IF10.8

2016-07-01

OAAI

Cohen, Keira A.; El-Hay, Tal; Wyres, Kelly L.; Weissbrod, Omer; Munsamy, Vanisha; Yanover, Chen; Aharonov, Ranit; Shaham, Oded; Conway, Thomas C.; Goldschmidt, Yaara; Bishai, William R.; Pym, Alexander S.

Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B

HAEMOPHILIA

IF3

2014-12-02

PREAI

Saini, S.; Hamasaki-Katagiri, N.; Pandey, G. S.; Yanover, C.; Guelcher, C.; Simhadri, V. L.; Dandekar, S.; Guerrera, M. F.; Kimchi-Sarfaty, C.; Sauna, Z. E.

Building better drugs: developing and regulating engineered therapeutic proteins

TRENDS IN PHARMACOLOGICAL SCIENCES

IF19.9

2013-10-01

PREAI

Kimchi-Sarfaty, Chava; Schiller, Tal; Hamasaki-Katagiri, Nobuko; Khan, Mansoor A.; Yanover, Chen; Sauna, Zuben E.

Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A

NATURE MEDICINE

IF50

2013-09-15

OAAI

Pandey, Gouri Shankar; Yanover, Chen; Miller-Jenkins, Lisa M.; Garfield, Susan; Cole, Shelley A.; Curran, Joanne E.; Moses, Eric K.; Rydz, Natalia; Simhadri, Vijaya; Kimchi-Sarfaty, Chava; Lillicrap, David; Viel, Kevin R.; Przytycka, Teresa M.; Pierce, Glenn F.; Howard, Tom E.; Sauna, Zuben E.

Observations regarding the immunogenicity of BDD-rFVIII derived from a mechanistic personalized medicine perspective

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2012-09-01

OAAI

Sauna, Z. E.; Ameri, A.; Kim, B.; Yanover, C.; Viel, K. R.; Rajalingam, R.; Cole, S. A.; Howard, T. E.

Pharmacogenetics and the immunogenicity of protein therapeutics

NATURE BIOTECHNOLOGY

IF41.7

2011-10-13

PREAI

Yanover, Chen; Jain, Nisha; Pierce, Glenn; Howard, Tom E.; Sauna, Zuben E.